Children and adolescents infected with severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) are predominantly asymptomatic or have mild symptoms compared with the …

Coronavirus disease 2019 (COVID-19) is an infectious disease caused by the severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) with substantial cardiovascular …

The American College of Cardiology (ACC) has a long history of developing documents (eg,
decision pathways, health policy statements, appropriate use criteria) to provide members …

Importance Refinement of criteria for multisystem inflammatory syndrome in children (MIS-C)
may inform efforts to improve health outcomes. Objective To compare clinical characteristics …

Background: Understanding the clinical course and short-term outcomes of suspected
myocarditis after the coronavirus disease 2019 (COVID-19) vaccination has important public …

Background The assessment of real-world effectiveness of immunomodulatory medications
for multisystem inflammatory syndrome in children (MIS-C) may guide therapy. Methods We …

To date, seven identified coronaviruses (CoVs) have been found to infect humans; of these,
three highly pathogenic variants have emerged in the 21st century. The newest member of …

Objective To provide guidance on the management of Multisystem Inflammatory Syndrome
in Children (MIS‐C), a condition characterized by fever, inflammation, and multiorgan …

Multisystem inflammatory syndrome in children (MIS-C) emerged in April 2020 in
communities with high COVID-19 rates. This new condition is heterogenous but resembles …

Immune-related manifestations are increasingly recognized conditions in patients with
COVID-19, with around 3,000 cases reported worldwide comprising more than 70 different …